XOMA Corporation (XOMA)
21.02
0.05 (0.24%)
At close: Mar 28, 2025, 11:55 AM
0.24% (1D)
| Bid | 20.46 |
| Market Cap | 251.79M |
| Revenue (ttm) | 22.64M |
| Net Income (ttm) | -14.15M |
| EPS (ttm) | -1.65 |
| PE Ratio (ttm) | -12.74 |
| Forward PE | -56.62 |
| Analyst | Buy |
| Ask | 21.41 |
| Volume | 567 |
| Avg. Volume (20D) | 40,793 |
| Open | 20.94 |
| Previous Close | 20.97 |
| Day's Range | 20.94 - 21.02 |
| 52-Week Range | 19.92 - 35.00 |
| Beta | 1.00 |
About XOMA
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with ...
Industry Biotechnology
Sector Healthcare
IPO Date Jun 6, 1986
Employees 13
Stock Exchange NASDAQ
Ticker Symbol XOMA
Website https://www.xoma.com
Analyst Forecast
According to 3 analyst ratings, the average rating for XOMA stock is "Buy." The 12-month stock price forecast is $74, which is an increase of 252.05% from the latest price.
Stock ForecastsNext Earnings Release
XOMA Corporation is scheduled to release its earnings on May 8, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-3.05%
XOMA Royalty shares are trading higher after the c...
Unlock content with
Pro Subscription
